Back to search

University of Ioannina

Newer markers of metabolic and cardiovascular diseases

Abstract

dc:description

Introduction. The prevalence of metabolic and cardiovascular diseases is increased and they are included among the most frequent causes of morbidity and mortality. Early diagnosis during childhood using reliable markers is essential for their prevention. Proteins like Fibroblast Growth Factor 21 (FGF21), leptin, adiponectin and insulin-like growth factor binding protein 1 (IGFBP1), have multiple actions on metabolism and have been partially studied in adults. Their role in the children is not completely understood. The aim of this study was to discover new markers and their potential role in metabolism and cardiovascular disease in pediatric population. Method. Seventy eight healthy children aged 7 to 16 years have been studied, anthropometric measurements and arterial blood pressure have been measured as well as biochemical markers including FGF21, leptin, adiponectin and IGFBP1 after overnight fasting. Ultrasound assessment with markers of early vascular dysfunction, brachial flow mediated dilation (FMD) and carotid intima-media thickness (cIMT) have been effectuated. The population has been divided in children with normal weight, overweight and obese, and in children with and without MS (International Diabetes Federation). Liver and thyroid hormone function, lipidemic profile and insulin resistance, have been studied. We have studied the potential correlation of the biomarkers with MS, obesity and with the metabolic disorders mentioned to investigate their diagnostic value. Results. FGF21 and leptin serum levels have been found to be significantly increased in overweight/obese children and in children with MS. FGF21 and leptin levels have been negatively correlated with IGFBP1 and positively correlated between them and with HOMAIR as well as with MS definition factors. Adiponectin serum levels have remained unchanged between the different groups. Serum levels of IGFBP1 have been found to be decreased in the serum of overweight/obese children and children with MS. From the markers studied only FGF21 and leptin have been correlated with FMD and this correlation remained significant after adjustment for BMI, age and sex only for FGF21. The diagnostic value of FGF21 serum levels have been calculated and we have found that above 121.3ng/L significantly predictedMS and for every 10ng/L increase of serum FGF21 levels the odds for MS have been increased by 10%. Based on these results, it has been shown that FGF21 could be used as a marker of metabolic and cardiovascular diseases in pediatric population, while leptin and IGFBP1 could constitute markers of metabolic diseases. Between the two vascular indices studied only FMD can be used for the evaluation of vascular dysregulation as it is influenced even in early stages, by mild metabolic disorders, in children. Conclusions. The levels of FGF21 were found to be significantly increased in the serum of obese children and children with MS in comparison to non-obese and children without MS. FGF21 negatively correlated with the index of endothelial dysfunction FMD and its increase inthe serum could predict the presence of MS in children. Leptin and IGFBP1 presented a correlation with features of MS but no correlation with the vascular indices and thus they could constitute markers of metabolic diseases. More research with larger prospective studies with long-term follow-up of children is needed to show whether FGF21 could constitute a prognostic biomarker of metabolic and cardiovascular diseases in pediatric population.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Domouzoglou, Eleni
  • Δομουζόγλου, Ελένη

Subjects

dc:subject × 26

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48182

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Domouzoglou, Eleni; Δομουζόγλου, Ελένη. Newer markers of metabolic and cardiovascular diseases. University of Ioannina, 2019. http://hdl.handle.net/10442/hedi/48182